Autobacs Seven Co., Ltd. Logo

Autobacs Seven Co., Ltd.

9832.T

(2.8)
Stock Price

1.431,00 JPY

3.12% ROA

4.45% ROE

20.01x PER

Market Cap.

114.815.078.133,00 JPY

4.96% DER

2.72% Yield

2.54% NPM

Autobacs Seven Co., Ltd. Stock Analysis

Autobacs Seven Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Autobacs Seven Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.97x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (6%), which means it has a small amount of debt compared to the ownership it holds

3 Dividend

Investors can trust the company's impressive dividend track record, consistently distributing dividends over the past five years, showcasing a strong commitment to rewarding shareholders.

4 ROE

The stock's ROE falls within an average range (5.45%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (3.92%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

7 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

8 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (64.717) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

11 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

Autobacs Seven Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Autobacs Seven Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Autobacs Seven Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Autobacs Seven Co., Ltd. Revenue
Year Revenue Growth
2003 227.078.000.000
2004 226.780.000.000 -0.13%
2005 240.207.000.000 5.59%
2006 242.532.000.000 0.96%
2007 266.429.000.000 8.97%
2008 259.144.000.000 -2.81%
2009 232.936.000.000 -11.25%
2010 236.350.000.000 1.44%
2011 237.342.000.000 0.42%
2012 230.168.000.000 -3.12%
2013 231.697.000.000 0.66%
2014 209.454.000.000 -10.62%
2015 208.142.000.000 -0.63%
2016 204.033.000.000 -2.01%
2017 211.630.000.000 3.59%
2018 213.840.000.000 1.03%
2019 221.400.000.000 3.41%
2020 220.449.000.000 -0.43%
2021 228.586.000.000 3.56%
2022 236.235.000.000 3.24%
2023 216.848.000.000 -8.94%
2023 229.856.000.000 5.66%
2024 216.044.000.000 -6.39%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Autobacs Seven Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Autobacs Seven Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Autobacs Seven Co., Ltd. EBITDA
Year EBITDA Growth
2003 12.526.000.000
2004 13.284.000.000 5.71%
2005 18.961.000.000 29.94%
2006 19.586.000.000 3.19%
2007 18.095.000.000 -8.24%
2008 14.522.000.000 -24.6%
2009 17.327.000.000 16.19%
2010 18.045.000.000 3.98%
2011 20.114.000.000 10.29%
2012 20.415.000.000 1.47%
2013 21.201.000.000 3.71%
2014 13.206.000.000 -60.54%
2015 12.040.000.000 -9.68%
2016 11.680.000.000 -3.08%
2017 12.654.000.000 7.7%
2018 12.377.000.000 -2.24%
2019 12.888.000.000 3.96%
2020 15.557.000.000 17.16%
2021 16.006.000.000 2.81%
2022 16.462.000.000 2.77%
2023 5.496.000.000 -199.53%
2023 13.293.000.000 58.65%
2024 9.515.000.000 -39.71%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Autobacs Seven Co., Ltd. Gross Profit
Year Gross Profit Growth
2003 67.806.000.000
2004 68.196.000.000 0.57%
2005 73.950.000.000 7.78%
2006 74.744.000.000 1.06%
2007 82.852.000.000 9.79%
2008 81.194.000.000 -2.04%
2009 73.996.000.000 -9.73%
2010 75.739.000.000 2.3%
2011 77.036.000.000 1.68%
2012 75.730.000.000 -1.72%
2013 76.907.000.000 1.53%
2014 66.902.000.000 -14.95%
2015 66.968.000.000 0.1%
2016 66.162.000.000 -1.22%
2017 67.370.000.000 1.79%
2018 67.581.000.000 0.31%
2019 70.747.000.000 4.48%
2020 73.289.000.000 3.47%
2021 77.150.000.000 5%
2022 79.462.000.000 2.91%
2023 72.480.000.000 -9.63%
2023 75.424.000.000 3.9%
2024 73.952.000.000 -1.99%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Autobacs Seven Co., Ltd. Net Profit
Year Net Profit Growth
2003 5.444.000.000
2004 2.928.000.000 -85.93%
2005 7.861.000.000 62.75%
2006 9.165.000.000 14.23%
2007 1.467.000.000 -524.74%
2008 -3.397.000.000 143.19%
2009 5.865.000.000 157.92%
2010 6.179.000.000 5.08%
2011 8.402.000.000 26.46%
2012 7.590.000.000 -10.7%
2013 9.786.000.000 22.44%
2014 4.609.000.000 -112.32%
2015 4.371.000.000 -5.44%
2016 3.015.000.000 -44.98%
2017 5.403.000.000 44.2%
2018 5.485.000.000 1.49%
2019 3.764.000.000 -45.72%
2020 7.050.000.000 46.61%
2021 7.010.000.000 -0.57%
2022 7.239.000.000 3.16%
2023 15.176.000.000 52.3%
2023 6.355.000.000 -138.8%
2024 2.920.000.000 -117.64%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Autobacs Seven Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 50
2004 27 -88.46%
2005 70 62.86%
2006 80 11.39%
2007 13 -558.33%
2008 -30 140%
2009 54 156.6%
2010 59 10.17%
2011 84 29.76%
2012 81 -3.7%
2013 108 24.3%
2014 53 -105.77%
2015 52 -1.96%
2016 36 -41.67%
2017 65 44.62%
2018 67 1.52%
2019 47 -40.43%
2020 88 46.59%
2021 89 1.12%
2022 93 3.26%
2023 0 0%
2023 82 100%
2024 37 -118.92%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Autobacs Seven Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2003 5.914.000.000
2004 4.631.000.000 -27.7%
2005 12.737.000.000 63.64%
2006 6.860.000.000 -85.67%
2007 -10.396.000.000 165.99%
2008 2.158.000.000 581.74%
2009 15.888.000.000 86.42%
2010 12.188.000.000 -30.36%
2011 13.154.000.000 7.34%
2012 4.493.000.000 -192.77%
2013 7.253.000.000 38.05%
2014 5.702.000.000 -27.2%
2015 4.669.000.000 -22.12%
2016 4.646.000.000 -0.5%
2017 12.807.000.000 63.72%
2018 -171.000.000 7589.47%
2019 7.174.000.000 102.38%
2020 13.167.000.000 45.52%
2021 -588.000.000 2339.29%
2022 3.505.000.000 116.78%
2023 0 0%
2023 5.282.000.000 100%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Autobacs Seven Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2003 13.808.000.000
2004 10.980.000.000 -25.76%
2005 24.137.000.000 54.51%
2006 17.216.000.000 -40.2%
2007 -645.000.000 2769.15%
2008 7.027.000.000 109.18%
2009 18.949.000.000 62.92%
2010 15.375.000.000 -23.25%
2011 20.844.000.000 26.24%
2012 10.741.000.000 -94.06%
2013 12.072.000.000 11.03%
2014 11.829.000.000 -2.05%
2015 10.564.000.000 -11.97%
2016 9.488.000.000 -11.34%
2017 16.394.000.000 42.13%
2018 4.447.000.000 -268.65%
2019 10.603.000.000 58.06%
2020 17.163.000.000 38.22%
2021 5.712.000.000 -200.47%
2022 10.687.000.000 46.55%
2023 0 0%
2023 14.431.000.000 100%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Autobacs Seven Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2003 7.894.000.000
2004 6.349.000.000 -24.33%
2005 11.400.000.000 44.31%
2006 10.356.000.000 -10.08%
2007 9.751.000.000 -6.2%
2008 4.869.000.000 -100.27%
2009 3.061.000.000 -59.07%
2010 3.187.000.000 3.95%
2011 7.690.000.000 58.56%
2012 6.248.000.000 -23.08%
2013 4.819.000.000 -29.65%
2014 6.127.000.000 21.35%
2015 5.895.000.000 -3.94%
2016 4.842.000.000 -21.75%
2017 3.587.000.000 -34.99%
2018 4.618.000.000 22.33%
2019 3.429.000.000 -34.67%
2020 3.996.000.000 14.19%
2021 6.300.000.000 36.57%
2022 7.182.000.000 12.28%
2023 0 0%
2023 9.149.000.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Autobacs Seven Co., Ltd. Equity
Year Equity Growth
2004 148.983.000.000
2005 161.536.000.000 7.77%
2006 167.995.000.000 3.84%
2007 165.205.000.000 -1.69%
2008 155.478.000.000 -6.26%
2009 151.852.000.000 -2.39%
2010 147.962.000.000 -2.63%
2011 146.193.000.000 -1.21%
2012 143.300.000.000 -2.02%
2013 144.362.000.000 0.74%
2014 138.552.000.000 -4.19%
2015 131.746.000.000 -5.17%
2016 127.390.000.000 -3.42%
2017 127.351.000.000 -0.03%
2018 124.184.000.000 -2.55%
2019 119.965.000.000 -3.52%
2020 123.832.000.000 3.12%
2021 122.889.000.000 -0.77%
2022 126.961.000.000 3.21%
2023 129.152.000.000 1.7%
2023 129.781.000.000 0.48%
2024 127.058.000.000 -2.14%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Autobacs Seven Co., Ltd. Assets
Year Assets Growth
2004 203.225.000.000
2005 227.707.000.000 10.75%
2006 240.628.000.000 5.37%
2007 234.126.000.000 -2.78%
2008 224.168.000.000 -4.44%
2009 210.652.000.000 -6.42%
2010 207.794.000.000 -1.38%
2011 217.948.000.000 4.66%
2012 205.526.000.000 -6.04%
2013 201.481.000.000 -2.01%
2014 186.531.000.000 -8.01%
2015 180.454.000.000 -3.37%
2016 176.708.000.000 -2.12%
2017 187.405.000.000 5.71%
2018 181.391.000.000 -3.32%
2019 172.799.000.000 -4.97%
2020 187.914.000.000 8.04%
2021 189.910.000.000 1.05%
2022 194.327.000.000 2.27%
2023 194.948.000.000 0.32%
2023 197.276.000.000 1.18%
2024 191.468.000.000 -3.03%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Autobacs Seven Co., Ltd. Liabilities
Year Liabilities Growth
2004 54.242.000.000
2005 66.171.000.000 18.03%
2006 72.633.000.000 8.9%
2007 68.921.000.000 -5.39%
2008 68.690.000.000 -0.34%
2009 58.800.000.000 -16.82%
2010 59.832.000.000 1.72%
2011 71.755.000.000 16.62%
2012 62.226.000.000 -15.31%
2013 57.119.000.000 -8.94%
2014 47.979.000.000 -19.05%
2015 48.708.000.000 1.5%
2016 49.318.000.000 1.24%
2017 60.054.000.000 17.88%
2018 57.207.000.000 -4.98%
2019 52.834.000.000 -8.28%
2020 64.082.000.000 17.55%
2021 67.021.000.000 4.39%
2022 67.366.000.000 0.51%
2023 65.793.000.000 -2.39%
2023 67.495.000.000 2.52%
2024 64.410.000.000 -4.79%

Autobacs Seven Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2901.78
Net Income per Share
73.62
Price to Earning Ratio
20.01x
Price To Sales Ratio
0.51x
POCF Ratio
21.35
PFCF Ratio
21.35
Price to Book Ratio
0.9
EV to Sales
0.4
EV Over EBITDA
9.1
EV to Operating CashFlow
16.97
EV to FreeCashFlow
16.97
Earnings Yield
0.05
FreeCashFlow Yield
0.05
Market Cap
114,82 Bil.
Enterprise Value
91,26 Bil.
Graham Number
1642.18
Graham NetNet
-54.73

Income Statement Metrics

Net Income per Share
73.62
Income Quality
0.94
ROE
0.04
Return On Assets
0.03
Return On Capital Employed
0.05
Net Income per EBT
0.6
EBT Per Ebit
1.36
Ebit per Revenue
0.03
Effective Tax Rate
0.4

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.33
Operating Profit Margin
0.03
Pretax Profit Margin
0.04
Net Profit Margin
0.03

Dividends

Dividend Yield
0.03
Dividend Yield %
2.72
Payout Ratio
0
Dividend Per Share
40

Operating Metrics

Operating Cashflow per Share
68.99
Free CashFlow per Share
68.99
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.03
Return on Tangible Assets
0.03
Days Sales Outstanding
40.23
Days Payables Outstanding
54.57
Days of Inventory on Hand
55.8
Receivables Turnover
9.07
Payables Turnover
6.69
Inventory Turnover
6.54
Capex per Share
0

Balance Sheet

Cash per Share
383,02
Book Value per Share
1.629,96
Tangible Book Value per Share
1530.54
Shareholders Equity per Share
1627.98
Interest Debt per Share
81.88
Debt to Equity
0.05
Debt to Assets
0.03
Net Debt to EBITDA
-2.35
Current Ratio
2.24
Tangible Asset Value
119,31 Bil.
Net Current Asset Value
42,73 Bil.
Invested Capital
116663000000
Working Capital
59,41 Bil.
Intangibles to Total Assets
0.04
Average Receivables
38,66 Bil.
Average Payables
22,36 Bil.
Average Inventory
22906000000
Debt to Market Cap
0.05

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Autobacs Seven Co., Ltd. Dividends
Year Dividends Growth
2001 36
2002 36 0%
2003 36 0%
2004 21 -71.43%
2005 29 27.59%
2006 54 46.3%
2007 60 10%
2008 120 50%
2009 110 -9.09%
2010 130 15.38%
2011 140 7.14%
2012 150 6.67%
2013 108 -38.89%
2014 40 -170%
2015 60 33.33%
2016 60 0%
2017 60 0%
2018 60 0%
2019 60 0%
2020 60 0%
2021 60 0%
2022 60 0%
2023 60 0%
2024 40 -50%
2025 0 0%

Autobacs Seven Co., Ltd. Profile

About Autobacs Seven Co., Ltd.

Autobacs Seven Co., Ltd., together with its subsidiaries, operates a chain of retail stores for automotive goods and services in Japan and internationally. It operates through Domestic AUTOBACS Business; Overseas Business; Car Dealership, BtoB and Online Alliance Business; and Other Business segments. The company's activities include wholesale and retail of automotive related goods, as well as installation services. It also purchases and sells cars; and provides services, including car maintenance and inspection, body repairing, and painting, etc. As of March 07, 2022, the company operated 493 AUTOBACS stores, 74 Super AUTOBACS stores, 6 AUTOBACS Secohan Ichiba stores, 11 AUTOBACS Express stores, and 3 AUTOBACS CARS stores, as well 59 overseas stores. It also operates an online store. The company was formerly known as Fuji-Syokai Co., Ltd. and changed its name to Autobacs Seven Co., Ltd. in March 1980. Autobacs Seven Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

CEO
Mr. Yugo Horii
Employee
4.385
Address
NBF Toyosu Canal Front
Tokyo, 135-8717

Autobacs Seven Co., Ltd. Executives & BODs

Autobacs Seven Co., Ltd. Executives & BODs
# Name Age
1 Mr. Yugo Horii
Chief Executive Officer & Representative Director
70
2 Masahiro Nishikawa
Executive General Manager Sales Operations
70
3 Mr. Shinichi Fujiwara
Senior Managing Director & Executive General Manager AUTOBACS Business Strategies
70
4 Shinya Kurahayashi
Executive General Manager of Car Trading Business & Finance Business
70
5 Mr. Eiichi Kumakura
Senior Managing Director
70
6 Hiroki Yoshiyama
Executive General Manager of Car Dealer Business
70
7 Mr. Masaru Sasaki
Executive General Manager of Property Development Business
70

Autobacs Seven Co., Ltd. Competitors